These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14566201)

  • 1. Treatment of panic disorder: focus on paroxetine.
    Pollack MH; Doyle AC
    Psychopharmacol Bull; 2003; 37 Suppl 1():53-63. PubMed ID: 14566201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine in panic disorder: clinical management and long-term follow-up.
    Dannon PN; Lowengrub K; Iancu I; Kotler M
    Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy studies of paroxetine in panic disorder.
    Lydiard RB; Steiner M; Burnham D; Gergel I
    Psychopharmacol Bull; 1998; 34(2):175-82. PubMed ID: 9640997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine treatment of generalized anxiety disorder.
    Sheehan DV; Mao CG
    Psychopharmacol Bull; 2003; 37 Suppl 1():64-75. PubMed ID: 14566202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
    Schruers K; Griez E
    J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine: a review of clinical experience.
    Dunner D; Kumar R
    Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term treatment of panic disorder.
    Davidson JR
    J Clin Psychiatry; 1998; 59 Suppl 8():17-21; discussion 22-3. PubMed ID: 9707158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of paroxetine with clocapramine in panic disorder.
    Saito M; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and tolerability of controlled-release paroxetine.
    Golden RN
    Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of panic disorder].
    Bougerol T; Farisse J
    Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders].
    Mosolov SN; Smulevich AB; Nuller IuL; Grigor'evskikh VS; Kostiukova EG; Kuzavkova MV; Koliutskaia EV; Andriushchenko AV; Zelenina EV; Kosinskiĭ VP; Kozlovskiĭ VL; Bykov SI; Pererva IG
    Ter Arkh; 2000; 72(10):16-23. PubMed ID: 11220870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants in panic disorder.
    Wade AG
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S13-7. PubMed ID: 10471168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
    Reznik AM; Arbuzov AL; Khurbatova IG
    Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.
    Perna G; Favaron E; Di Bella D; Bussi R; Bellodi L
    Neuropsychopharmacology; 2005 Dec; 30(12):2230-5. PubMed ID: 16034444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.
    Marchesi C; De Panfilis C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1240-5. PubMed ID: 16678956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.